Considering the small number of ER-positive and HER2-negative breast cancer samples, more studies with larger sample size are needed to further confirm the relationship between methylation of these genes and lymph node metastasis. This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.